Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning. Amazon.com Inc. (NASDAQ: AMZN) Raised to Outperform at William Blair. Amgen Inc.…
Investors love huge biotech opportunities for growth. Investors also love to get paid in the form of dividends. Unfortunately, the terms “dividend” and “biotech” never match up. While some hopes have been…
Despite big companies holding unprecedented billions and billions of dollars on their balance sheets, it is shocking how many companies do not reward shareholders in the most classic sense by paying regular…
Earnings season is in full swing and we have a back-breaker of an earnings week ahead of us. There are some 11 DJIA components reporting earnings and a whole slew of other…
After about two weeks of being quiet and dark, Wall Street research departments are back after the holidays. These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in…
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been…
These are some of this Wednesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. ABB Ltd. (NYSE: ABB) Raised to Buy at Stern Agee. Akamai Technologies Inc. (NASDAQ:…
These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Raised to Outperform at Leerink Swann. AON Corporation (NYSE: AON)…
The Battelle Memorial Institute, which looks at R&D in major nations, says that China will pass Japan as the No.2 spender next year. “China is expected to spend $153.7 billion on R&D…
These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Raised to Overweight at Piper Jaffray. AT&T Inc. (NYSE: T)…
These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Started as Neutral at Credit Suisse. AstraZeneca (NYSE: AZN) Cut…
Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may take a resolution of the Genzyme Corporation (NASDAQ: GENZ) merger, and a…
Earnings season is in full swing and the peak will occur next week. We have several DJIA components reporting earnings along with several other companies which are equally as important to the…
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news…
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc. (NASDAQ: AMGN) Started as Buy at Stifel Nicolaus. AngloGold Ashanti (NYSE: AU)…
